In 33/53 (62.3%) cases we observed a slight agreement for RASSF1A promoter methylation between primary tumor samples and corresponding plasma, (P=0.227, 2-sided Pearson χ2 test, k=0.156) (Table 2). This evidence concerns the gene RASSF1 and neoplasm.